Monroe, NY, United States of America

Marc Sadler Tesconi

USPTO Granted Patents = 6 

 


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Marc Sadler Tesconi: Innovator in Pharmaceutical Chemistry

Introduction

Marc Sadler Tesconi is a notable inventor based in Monroe, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on innovative compounds and methods that have the potential to impact various medical treatments.

Latest Patents

Among his latest patents is a crystalline form of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile. This invention is directed to a crystalline monohydrate with a specific x-ray diffraction pattern and a transition temperature ranging from about 109°C to about 115°C. Another significant patent involves tanaproget polymorph Form II, which includes processes for preparing this polymorph, pharmaceutical compositions, and methods for treating various medical conditions such as uterine fibroids and endometriosis.

Career Highlights

Marc Sadler Tesconi is currently employed at Wyeth, a prominent pharmaceutical company. His work at Wyeth has allowed him to focus on developing innovative solutions in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and application of complex pharmaceutical compounds.

Collaborations

Throughout his career, Marc has collaborated with several talented individuals, including Mannching Sherry Ku and Yan Xu. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Marc Sadler Tesconi's work exemplifies the spirit of innovation in pharmaceutical chemistry. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…